IRCT138712071715N1已完成1 期
Vaccination of diffuse B cell lymphoma patients by use of tumor antigens and autologous dendritic cells complex
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 60 years（—）
- 性别
- All
入选标准
- •Presence of diffuse b cell lymphoma
- •Exclusion criteria: Presence o any other kind of cancer except for lymphoma
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Response to vaccination in lymphoma patients treated with CHOP and rituximab.cancer of the lymph nodes1004743810025320LymphomaNL-OMON38294Sint Antonius Ziekenhuis160
撤回
不适用
Vaccination response in lymphoma patients treated with CHOP and rituximabB-cell malignancylymph node cancer1002532010004018NL-OMON32777Sint Antonius Ziekenhuis140
已完成
2 期
Vaccination with recombinant lymphoma idiotype in indolent lymphoma in advanced stagesIndolent B cell lymphomaC82C83.0C83.1Small cell B-cell lymphomaFollicular lymphomaMantle cell lymphomaDRKS00000227Abteilung Innere Medizin IUniversitätsklinikum Freiburg42
招募中
不适用
Intradermal Hepatitis-B-vaccination in non-responders after application of imiquimod 5% at the site of vaccination.non-responsiveness to hepatitis B vaccination (with recombinant vaccine).NL-OMON24074A.H.E. Roukens, MDL.G. Visser, MD, PhD26
招募中
不适用
Rabiës pre exposure prophylaxis in patients with auto-immune diseases using immunosuppressive agents.NL-OMON25639The International Society of Travel Medicine (ISTM)50